| Business Summary | | Hi-Tech
Pharmacal
Co.,
Inc.
is
a
specialty
manufacturer
and
marketer
of
prescription,
over-the-counter
and
nutritional
products.
The
Company
sells
its
products
in
three
similar
markets:
generic
pharmaceuticals,
branded
products
and
contract
manufacturing.
The
Company
markets
its
generic
pharmaceuticals
under
the
brand
names
H-T
and
RX
Choice.
The
Company
markets
a
line
of
branded
products
primarily
for
people
with
Diabetes,
including
Diabetic
Tussin,
DiabetiDerm,
DiabetiSweet,
DiabetiGest
and
DiabetiRinse.
In
addition,
the
Company
markets
other
niche
over-the-counter
brands
to
the
general
healthcare
marketplace
under
such
brands
as
Kosher
Care,
Nasal
Ease
and
Soothing
Comfort.
The
Company
specializes
in
the
manufacture
of
liquid,
cream
and
ointment
formulations.
It
also
manufactures
products
in
a
state-of-the-art
sterile
facility
capable
of
producing
ophthalmic,
otic
and
inhalation
products.
Hi-Tech
Pharmacal
markets
more
than
70
products
to
approximately
100
customers. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Hi-Tech
Pharmacal
Co.
develops,
manufactures
and
markets
over-the-counter,
prescription
and
nutritional
products.
The
Company
also
produces
sterile
ophthalmic,
otic
and
inhalation
products
and
provides
contract
services.
For
the
fiscal
year
ended
4/30/01,
net
sales
rose
12%
to
$29.6
million.
Net
income
rose
41%
to
$2.4
million.
Results
reflect
increased
shipments
to
existing
customers,
the
addition
of
new
customers
and
higher
margins
due
to
changes
in
sales
mix. | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| Bernard Seltzer, 77 Chairman | $252K | David Seltzer, 41 Pres,
CEO, Sec., Treasurer, Director | 449K | Arthur Goldberg, 59 CFO,
VP-Fin. | 132K | Elan Bar-Giora, 57 Exec.
VP- Operations | 172K | Dollar amounts are as of 30-Apr-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|